Rebecca B. Raftogianis
Mayo Clinic
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rebecca B. Raftogianis.
The FASEB Journal | 1997
Richard M. Weinshilboum; Diane M. Otterness; Ibrahim A. Aksoy; Thomas C. Wood; Chengtao Her; Rebecca B. Raftogianis
Sulfotransferase (ST) enzymes cata‐lyze the sulfate conjugation of many hormones, neu‐rotransmitters, drugs, and xenobiotic compounds. These reactions result in enhanced renal excretion of the sulfate‐conjugated reaction products, but they can also lead to the formation of “bioactivated” metabolites. ST enzymes are members of an emerging gene superfamily that presently includes phenol ST (PST), hydroxysteroid ST (HSST), and, in plants, flavonol ST (FST) “families,” members of which share at least 45% amino acid sequence iden‐tity. These families can be further subdivided into “subfamilies” that are at least 60% identical in amino acid sequence. For example, the PST family includes both PST and estrogen ST (EST) subfamilies. Amino acid sequence motifs exist within ST enzymes that are conserved throughout phylogeny. These signature sequences may be involved in the binding of 3 ‘‐phosphoadenosine‐5 ‘‐phosphosulfate, the cosubstrate for the sulfonation reaction. There are presently five known human cytosolic ST en‐zymes: an EST, an HSST, and three PSTs. cDNAs and genes for all of these enzymes have been cloned, and chromosomal localizations have been reported for all five genes. Genes for these human enzymes, as well as those of other mammalian cytosolic ST enzymes that have been cloned, show a high degree of structural homology, with conservation of the lo‐cations of most intron/exon splice junctions. Human ST enzyme expression varies among individuals. Functionally significant genetic polymorphisms for ST enzymes in humans have been reported, and other molecular genetic mechanisms that might be involved in the regulation of the expression of these enzymes are being explored. Knowledge of the mo‐lecular biology of cytosolic ST enzymes, when placed within a context provided by decades of biochemical research, promises to significantly enhance our understanding of the regulation of the sulfate conjugation of hormones, neurotransmitters, and drugs.—Weinshilboum, R. M., Otterness, D. M., Aksoy, I. A., Wood, T. C., Her, C., Rafto‐ gianis, R. B. Sulfotransferase molecular biology: cDNAs and genes. FASEB J. 11, 3‐14 (1997)
Clinical Pharmacology & Therapeutics | 1996
Chengtao Her; Rebecca B. Raftogianis; Richard M. Weinshilboum
Clinical Pharmacology & Therapeutics (1996) 59, 216–216; doi: 10.1038/sj.clpt.1996.362
Biochemical and Biophysical Research Communications | 1997
Rebecca B. Raftogianis; Thomas C. Wood; Diane M. Otterness; Jon A. Van Loon; Richard M. Weinshilboum
Biochemical Pharmacology | 1999
Rebecca B. Raftogianis; Thomas C. Wood; Richard M. Weinshilboum
Journal of The National Cancer Institute Monographs | 2000
Rebecca B. Raftogianis; Cyrus R. Creveling; Richard M. Weinshilboum; Judith Weisz
Molecular Pharmacology | 1998
Charles Preuss; Thomas C. Wood; Carol L. Szumlanski; Rebecca B. Raftogianis; Diane M. Otterness; Blanka Girard; Mary C. Scott; Richard M. Weinshilboum
Pharmacogenetics | 2001
Edward J. Carlini; Rebecca B. Raftogianis; Thomas C. Wood; Fan Jin; Wei Zheng; Timothy R. Rebbeck; Richard M. Weinshilboum
Genomics | 1996
Chengtao Her; Rebecca B. Raftogianis; Richard M. Weinshilboum
Pharmacogenetics | 1996
Rebecca B. Raftogianis; Chengtao Her; Richard M. Weinshilboum
Genomics | 2000
Robert R. Freimuth; Rebecca B. Raftogianis; Thomas C. Wood; Eunpyo Moon; Ung Jin Kim; Jingping Xu; Michael J. Siciliano; Richard M. Weinshilboum